Martek Biosciences Corporation to Royal DSM N.V.

EV / LTM EBITDA

8.8x

EV / LTM Sales

Enterprise Value

Primary Source

Evercore

All Observations

Source-specific multiples and notes for this transaction.

Primary?	Source Type	Fairness Opinion / Source	Advisor	Source Year	Enterprise Value	EV/Sales	EV/EBITDA	EV/Fwd EBITDA	Note	Citation
Primary	fairness opinion	NTRI FO	Evercore	2018	-	-	8.8x	-	-	Open